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cultures in published medical literature from Turkey in the
1997—2001 and 2002-September 2007 periods.
Method: To ﬁnd out the published series three
national databases (Ulakbim Turkish Medical Liter-
ature database, http://www.turkishmedline.com,
http://medline.pleksus.com.tr) and two international
databases (Pubmed and Science Citation Index (SCI))
were searched. Keywords for national databases were
[“idrar yolu infeksiyonu” or “idrar yolu enfeksiyonu” or
“urinary tract infection” or “u¨riner sistem infeksiyonu” or
“u¨riner sistem enfeksiyonu”]. Keywords for Index Medicus
and SCI-expanded were [“urinary tract infection” and
Turkey]. Articles i)published before 1997 ii)resistance data
of outpatient and inpatient strains were not analysed
seperately iii)antibiotic susceptibility data were not given,
were excluded. All studies used Kirby-Bauer disc diffusion
test by using NCCLS/CLSI criteria for determination of
antimicrobial resistance. Resistance data of inpatient and
outpatient strains were compared by Chi-square test. A p
value less than 0.05 was considered signiﬁcant.
Results: Data for 25577 E.coli strains were obtained from
53 articles (28 articles from 1997—2001 period, 25 from
2002—2007 period). Of these starins 18106 were isolated
from outpatients whereas 7471 from inpatients. The resis-
tance rates and comparisons of 1997—2001 and 2002—2007
periods are shown in Table 1.
Conclusions: Trimethoprim sulphametoxazole resistance
is very high and it cannot be recommended in the empiri-
cal treatment any more. Nitrofurantoin may be a cheap and
reasonable option in uncomplicated UTI. Aminoglycosides
and third-generation cephalosporins may be good choices
in the treatment of complicated UTI. Carbapenems may be
conserved for extended-spectrum beta lactamase producing
strains. ESBL rate in the outpatient strains is alarming. Poli-
cies to constrain resistance such as antibiotic stewardship
or restriction programmes should be implemented immedi-
ately.
doi:10.1016/j.ijid.2008.05.282
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Background: Acinetobacters (AC) other than A. bauman-
nii (ACOB) are occasionally recovered from clinical sources,
but OXA and MBL genes have rarely been reported. The aim
of this study was to identify and characterize OXA and MBL
genes in AC. Gene context of blaOXA-23 detected in A. radiore-
sistans (AR) was also evaluated.
Methods: AC recovered from patients in 10 countries in
the Asia-Paciﬁc (APAC) region were tested by broth microdi-
lution. Isolates with imipenem or meropenem MIC ≥8mg/L
were screened for MBL- (IMP-like, VIM-like, SIM-1, GIM-1,
SPM-1) and OXA- (OXA-23, -24, -58 clusters) genes. OXA
genes and surrounding sequences were assessed by PCR
using primers targeting to ISAba1, 2 or 3, or degenerate
primer approach. Southern blot and hybridization of chro-
mosomal and plasmid DNA were performed. RNA extraction
followed by reverse transcriptase-PCR was performed to
access expression of blaOXA-23. Species identiﬁcation was
conﬁrmed by 16S rRNA.
Results: Among 543 AC isolates, 28.2% carried OXA
(98.7%) or MBL (1.3%) genes, from which 2.6% were found
ACOB. An A. junii (AJ) with blaOXA-23 and an AR with blaOXA-23
and blaOXA-58 were detected in 2 Indian centers, while an
A. johnsonnii with blaIMP-4 and A. calcoaceticus (ACA) with
blaOXA-58 were identiﬁed in the Philippines and China, respec-
tively. ISAba1 and ISAba3 surrounded blaOXA-23 from AJ and
blaOXA-58 from AR and ACA, respectively. The AR showed a
putative O-sialoglycoprotein endopeptidase-encoding gene
upstream of blaOXA-23; gene expression was not detected;
and blaOXA-23 and blaOXA-58 were located on the chromosome
and plasmid, respectively. Susceptibility to polymyxin and
tigecycline (≤2mg/L; no breakpoint criteria) was ≥98.9%.
Conclusion: High dissemination of OXA genes was
detected, emphasizing their ability to spread among AC.
The data suggest AR may be a natural reservoir for blaOXA-23.
blaIMP-4 has been previously detected in Hong Kong, Australia
and now Philippines, highlighting spread in APAC.
doi:10.1016/j.ijid.2008.05.283
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Background: Diminishing clinical response to
ciproﬂoxacin (CIP) therapy at ICDDR, B correlated with
decreased minimum inhibitory concentration (MIC) of
V. cholerae to CIP, though strains remained susceptible
using standard thresholds. To determine the cause of the
diminished susceptibility, we investigated mutations in the
quinolone-resistance-determining-region/analogous region
of genes gyrA/B and parC/E that encode, respectively,
quinolone targets DNA gyrase and topoisomerase IV.
Method: We studied 30 clinical isolates of V. cholerae O1
and 10 of V. cholerae O139 isolated during 1993—2006. Sus-
ceptibility was determined by standard disk diffusion (DD)
and E-test methods and interpreted according to CLSI and
manufacturer’s instruction respectively. We extracted chro-
mosomal DNA, ampliﬁed and sequenced the gene fragments
and then edited, matched and aligned the sequences using
suitable methods and software to identify mutations.
Results: No mutation was detected in 9 strains having a
CIP MIC of 0.002—0.003 and a NA MIC of 0.125—0.5g/ml; a
substitution (Asparticacid87Asparagine) was noted in gyrA
was noted in 2 strains with a CIP MIC of 0.008—0.012
and a NA MIC of 4—8g/ml; a unique gyrA mutation in
